UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031939
Receipt number R000036448
Scientific Title The clinical trial of CoQ10 for saliva secresion or periodontal disease.
Date of disclosure of the study information 2018/04/25
Last modified on 2019/07/29 17:51:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The clinical trial of CoQ10 for saliva secresion or periodontal disease.

Acronym

The effect of CoQ10 on saliva secresion.

Scientific Title

The clinical trial of CoQ10 for saliva secresion or periodontal disease.

Scientific Title:Acronym

The effect of CoQ10 on saliva secresion.

Region

Japan


Condition

Condition

Dry mouth

Classification by specialty

Oral surgery Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The effect of CoQ10 on periodentol disease mainly of saliva secresion.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

saliva secretion, oxidative stress of blood or saliva, saliva CoQ10 determination, Inspection of periodontal tissues.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

6

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Dry mouth patients, placebo, 1month

Interventions/Control_2

Healthy volunteer. placebo, 1month

Interventions/Control_3

Dry mouth patients, ubiquinol, 100mg/day, 1month

Interventions/Control_4

Healthy volunteer, ubiquinol, 100mg/day, 1month

Interventions/Control_5

Dry mouth patients, ubiquinone, 100mg/day, 1month

Interventions/Control_6

Healthy volunteer, ubiquinone, 100mg/day, 1month

Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

The subjects underwent an evaluation of salivary secresion using the Saxon's test were divied into a dry mouth group (salivary secretion<2g/2min) and a healthy subjects group (salivary secretion 2>g/2min).

Key exclusion criteria

Patients who had a medical history of significant cardiovascular disease, significant pulmonary obstructive disease, gastrointestinal obstructive disease, epilepsy, or Parkinson's disease.
Patients currently using drugs known to be xerostomic, taking disease-modifying anti-rheumatic drugs or predonisolone, undergoing radiotherapy for treatment of head and neck cancer.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Koufuchi
Middle name
Last name Ryo

Organization

Departments of Geriatric Dentistry

Division name

Tsurumi University School of Dental Medicine

Zip code

230-8501

Address

2-1-3 Tsurumi, Tsurumi-ku, Yokohama, Japan

TEL

045-572-2888

Email

saito-i@tsurumi-u.ac.jp


Public contact

Name of contact person

1st name Ichiro
Middle name
Last name Saito

Organization

Tsurumi University School of Dental Medicine

Division name

Department of Pathology

Zip code

230-8501

Address

2-1-3 Tsurumi, Tsurumi-ku, Yokohama, Japan

TEL

045-572-2888

Homepage URL


Email

saito-i@tsurumi-u.ac.jp


Sponsor or person

Institute

Tsurumi University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports Sicence, and Technology of Japan

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The ethics committees of Tsurumi University

Address

2-1-3 Tsurumi, Tsurumi-ku, Yokohama, Kanagawa, Japan

Tel

045-581-1001

Email

rinrishinsa@tsurumi-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 04 Month 25 Day


Related information

URL releasing protocol

.

Publication of results

Published


Result

URL related to results and publications

.

Number of participants that the trial has enrolled

0

Results

.

Results date posted

2019 Year 07 Month 29 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

.

Participant flow

.

Adverse events

.

Outcome measures

.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2005 Year 07 Month 12 Day

Date of IRB


Anticipated trial start date

2006 Year 01 Month 01 Day

Last follow-up date

2007 Year 08 Month 31 Day

Date of closure to data entry

2008 Year 01 Month 01 Day

Date trial data considered complete

2008 Year 07 Month 15 Day

Date analysis concluded

2009 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2018 Year 03 Month 28 Day

Last modified on

2019 Year 07 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036448


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name